B-hGUCY2C MC38

• 321837

B-hGUCY2C B16-F10
B-hHER2 CT26.WT

B-hGUCY2C MC38

Product nameB-hGUCY2C MC38
Catalog number321837
Strain backgroundC57BL/6
NCBI gene ID2984 (Human)
AliasesGUCY2C
TissueColon
DiseaseColon carcinoma
SpeciesMouse
ApplicationB-hGUCY2C MC38 cells have the capability to establish tumors in C57BL/6 mice in vivo and can be used for efficacy studies.

이 페이지에서

  • Description
  • Targeting strategy
  • Phenotypic analysis
  • Tumorigenicity

포스터

모두 보기

    출판물

      Description

      The chimeric CDS consist of human GUCY2C extracellular plus mouse Gucy2c intracellular region sequences was inserted to mouse Gucy2c gene exon 1 in B-hGUCY2C MC38 cells, so that the mouse GUCY2C was not expressed anymore, human GUCY2C is highly expressed on the surface of B-hGUCY2C MC38 cells.

      Tageting strategy

      Gene targeting strategy for B-hGUCY2C MC38 cells. The exogenous promoter and chimeric CDS consist of human GUCY2C extracellular plus mouse Gucy2c intracellular region sequences were inserted to mouse Gucy2c gene exon 1 in B-hGUCY2C MC38 cells.

      Protein expression analysis
      GUCY2C expression analysis in B-hGUCY2C MC38 cells by flow cytometry. Single cell suspensions from B-hGUCY2C MC38 cultures were stained with species-specific anti-GUCY2C antibody. Human GUCY2C were detected on the surface of B-hGUCY2C MC38 cells. The 2-B03 clone of B-hGUCY2C MC38 cells was used for in vivo experiments.
      Protein expression analysis of tumor cells

      B-hGUCY2C MC38 cells were subcutaneously transplanted into C57BL/6N mice (n=8). At the end of the experiment, tumor cells were harvested and assessed for human GUCY2C expression by flow cytometry. As shown, human GUCY2C was highly expressed on the surface of tumor cells. Therefore, B-hGUCY2C MC38 cells can be used for in vivo efficacy studies of novel GUCY2C therapeutics.

      Tumor growth curve & Body weight changes

      Subcutaneous homograft tumor growth of B-hGUCY2C MC38 cells. B-hGUCY2C MC38 cells (1x106 ,5x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6N mice (female, 7-week-old). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean ± SEM). Volume was expressed in mm3 using the formula: V=0.5 × long diameter × short diameter2. As shown in panel A, B-hGUCY2C MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

      Tumor growth curve of individual mice

      B-hGUCY2C MC38 tumor growth of individual mice. B-hGUCY2C MC38 cells (1x106 ,5x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6N mice (female, 7-week-old). As shown in panel, B-hGUCY2C MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

      Tumor growth curve & Body weight changes

      Subcutaneous homograft tumor growth of B-hGUCY2C MC38 cells. B-hGUCY2C MC38 cells and wild-type MC38 cells were subcutaneously implanted into B-h4-1BB mice mice (female, 9-week-old). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean ± SEM). Volume was expressed in mm3 using the formula: V=0.5 × long diameter × short diameter2. As shown in panel A, B-hGUCY2C MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

      Tumor growth curve of individual mice

      B-hGUCY2C MC38 tumor growth of individual mice. B-hGUCY2C MC38 cells and wild-type MC38 cells were subcutaneously implanted into B-h4-1BB mice mice (female, 9-week-old). As shown in panel, B-hGUCY2C MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.